China Pharma shareholders OK reverse split up to 1:10; NYSE compliance partially restored

3. A proposal to amend the Company’s Articles of Incorporation to effect a reverse stock split at a ratio of up to 1:10, such that every holder of common stock, par value $0.001 per share, of the Company, shall receive one share of Common Stock for up to every ten shares of Common Stock held: Votes For Votes Against Abstentions 17,060,203 165,541 253 Pursuant to the foregoing votes, an amendment to the Company’s Articles of Incorporation to effect a reverse stock split at a ratio of up to 1:10, such that every holder of common stock, par value $0.001 per share, of the Company, shall receive one share of Common Stock for up to every ten shares of Common Stock held was approved and adopted.

2. A proposal to adopt the Amendment No.1 to the Company’s Amended and Restated 2010 Long-Term Incentive Plan: Votes For Votes Against Abstentions 17,073,265 147,382 5,350 Pursuant to the foregoing votes, the Amendment No.1 to the Company’s Amended and Restated 2010 Long-Term Incentive Plan was approved and adopted.

1. A proposal to elect three independent director nominees to our Board of Directors: Independent Director’s Name Votes For Votes Withheld Gene Michael Bennett 17,174,742 51,255 Yingwen Zhang 17,165,245 60,752 Baowen Dong 17,165,232 60,765 Pursuant to the foregoing votes, Gene Michael Bennett, Yingwen Zhang and Baowen Dong were elected to serve as our independent directors until the next annual meeting and until their successors are elected and qualified.